Clinical Trial Update: An Immunologic Study of Treatment-Naive HIV Patients Starting a Darunavir/Ritonavir- or Efavirenz-Based HAART

View source ↗

Summary

This completed clinical trial compared a darunavir/ritonavir-based HAART regimen with an efavirenz-based regimen in treatment-naive HIV patients. The document n…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• EFAVIRENZ (efavirenz)
• darunavir/ritonavir (darunavir/ritonavir)

Snippet

Sponsor: Janssen-Cilag S.p.A. | Conditions: Human Immunodeficiency Virus; HIV | Status: COMPLETED